JBC INTERFERin siRNA transfection reagent

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.C100588200 on December 21, 2001

J. Biol. Chem., Vol. 277, Issue 7, 4601-4604, February 15, 2002
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/7/4601    most recent
C100588200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fukuda, M.
Right arrow Articles by Mikoshiba, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fukuda, M.
Right arrow Articles by Mikoshiba, K.

ACCELERATED PUBLICATION
Synaptotagmin IX Regulates Ca2+-dependent Secretion in PC12 Cells*

Mitsunori FukudaDagger §, Judith A. Kowalchyk, Xiaodong Zhang, Thomas F. J. Martin, and Katsuhiko MikoshibaDagger ||

From the Dagger  Laboratory for Developmental Neurobiology, Brain Science Institute, RIKEN (The Institute of Physical and Chemical Research), 2-1 Hirosawa, Wako, Saitama 351-0198, Japan, the  Department of Biochemistry, University of Wisconsin, Madison, Wisconsin 53706, and the || Division of Molecular Neurobiology, Department of Basic Medical Science, The Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan

Received for publication, October 11, 2001, and in revised form, December 9, 2001

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

Synaptotagmin (Syt) I-deficient phaeochromocytoma (PC12) cell lines show normal Ca2+-dependent norepinephrine (NE) release (Shoji-Kasai, Y., Yoshida, A., Sato, K., Hoshino, T., Ogura, A., Kondo, S., Fujimoto, Y., Kuwahara, R., Kato, R., and Takahashi, M. (1992) Science 256, 1821-1823). To identify an alternative Ca2+ sensor, we searched for other Syt isoforms in Syt I-deficient PC12 cells and identified Syt IX, an isoform closely related to Syt I, as an abundantly expressed dense-core vesicle protein. Here we show that Syt IX is required for the Ca2+-dependent release of NE from PC12 cells. Antibodies directed against the C2A domain of either Syt IX or Syt I inhibited Ca2+-dependent NE release in permeable PC12 cells indicating that both Syt proteins function in dense-core vesicle exocytosis. Our results support the idea that Syt family proteins that co-reside on secretory vesicles may function cooperatively and redundantly as potential Ca2+ sensors for exocytosis.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

Neurotransmitter release is achieved by fusion of synaptic vesicles to presynaptic plasma membranes (i.e. exocytosis) in response to a rapid increase in Ca2+ ions entering through voltage-gated Ca2+ channels. Ca2+-binding proteins (so-called "Ca2+ sensors") (for reviews, see Refs. 1 and 2) must be present on the synaptic vesicles to sense such rapid increases in Ca2+ ions. Genetic and biochemical evidence during the past decade indicates that synaptotagmin I (Syt I),1 a Ca2+-binding protein abundant in synaptic vesicles, is the most likely candidate for the major Ca2+ sensor for neurotransmitter release in the central nervous system (Ref. 3 and reviewed in Refs. 4-6). Syt I contains one transmembrane region at the amino terminus and two C2 domains (the C2A domain and C2B domain) in the cytoplasmic domain, and Ca2+ binding to the C2A domain is essential for regulating Ca2+-dependent neurotransmitter release (3). Syt I is also found in the secretory granules of some endocrine cells (e.g. chromaffin cells, pancreatic beta -cell lines, and PC12 cells) and has been shown to be involved in Ca2+-dependent endocrine exocytosis by peptide or antibody injection experiments (7-10), suggesting a role of Syt I as an endocrine Ca2+ sensor (11). However, in 1992, Syt I-deficient PC12 cell lines exhibiting normal Ca2+-dependent norepinephrine (NE) release were established (12). Their existence strongly contradicts the notion that Syt I is the major Ca2+ sensor for endocrine exocytosis (12), and the presence of an alternate Ca2+ sensor for Syt I in PC12 cells has been proposed (e.g. rabphilin, Doc2, calmodulin, and frequenin) (13-16). However, the actual alternative Ca2+ sensor to Syt I in PC12 cells has not yet been identified.

In this study we show that Syt IX is a major Syt isoform that is abundantly expressed on dense-core vesicles and regulates Ca2+-dependent secretion in PC12 cells. Based on our finding, we discuss the functional relationship between Syt I and Syt IX in PC12 cells.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

Antibody Purification-- The anti-Syt I mouse monoclonal antibody (Ab) (SYA148) was from StressGen. The anti-Syt I-C2A rabbit Ab was prepared as described previously (17, 18). New Zealand White rabbits were immunized with the purified glutathione S-transferase (GST)-Syt IX-C2A (19), and the anti-Syt IX-C2A Ab was affinity-purified by exposure to antigen bound to Affi-Gel 10 beads (Bio-Rad) as described previously (17, 20). The cross-reactive component to Syt I was removed by incubation with glutathione-Sepharose (Amersham Biosciences, Inc.) coupled to 1 mg of GST-Syt I-C2A proteins (20). The Abs specific for the amino-terminal domain of mouse Syt I (anti-Syt I-N) and Syt IX (anti-Syt IX-N) were raised against the following synthetic peptides: MVSASRPEALAAPVTTVATC (Syt I-N) and KTPPDSSRIRQGAVC (Syt IX-N). The Abs were affinity-purified by exposure to antigenic peptide bound to FMP-activated Cellulofine (Seikagaku Co.) as described previously (21). Specificity of these antibodies was checked by immunoblotting using recombinant T7-tagged Syts I-XIII expressed in COS-7 cells (22-24). Under our experimental conditions, we could not observe cross-reactivity of anti-Syt IX-C2A and anti-Syt IX-N Abs with Syt I in immunoblotting. The protein concentration was determined with a Bio-Rad protein assay kit using bovine serum albumin as a reference. Immunoblotting was performed as described previously (20, 23).

Antibody Uptake Experiments-- The purified anti-Syt I-N and anti-Syt IX-N Abs were conjugated with 5-(and-6)-carboxytetramethylrhodamine (Molecular Probes catalog no. C-1171) and 5-carboxyfluorescein (Molecular Probes catalog no. C-2210), respectively, according to the instructions of the manufacturer (17, 25). Nerve growth factor-differentiated PC12 cells were cultured on 35-mm glass-bottom dishes coated with collagen type IV (MaTek Corp.) in Dulbecco's modified Eagle's medium containing 10% horse serum and 10% fetal bovine serum at 37 °C under 5% CO2. After washing twice with phosphate-buffered saline, the cells were stimulated for 10 min at 37 °C with either low KCl buffer (5.6 mM KCl, 145 mM NaCl, 2.2 mM CaCl2, 0.5 mM MgCl2, 5.6 mM glucose, and 15 mM HEPES-KOH, pH 7.4) or high KCl buffer (56 mM KCl, 95 mM NaCl, 2.2 mM CaCl2, 0.5 mM MgCl2, 5.6 mM glucose, and 15 mM HEPES-KOH, pH 7.4) containing rhodamine-labeled anti-Syt I-N Ab (1 µg/ml) and fluorescein-labeled anti-Syt I Ab (10 µg/ml). The cells were immediately washed twice with phosphate-buffered saline and then fixed in 4% paraformaldehyde in 0.1 M sodium phosphate buffer for 20 min at room temperature as described previously (20, 22). Incorporated antibodies were analyzed with a fluorescence microscope (TE300, Nikon) attached to a laser confocal scanner unit CSU 10 (Yokogawa Electric Corp.) and HiSCA CCD camera (C6790, Hamamatsu Photonics). Images were pseudo-colored and superimposed with Adobe Photoshop software (Version 4.0) (20, 22).

Assays for Ca2+-activated Exocytosis-- Assays of the Ca2+-triggered release of [3H]NE from permeable PC12 cells were conducted as described previously (26). PC12 cells, cultured as described previously (27), were incubated with 0.5 µC/ml [3H]NE (Amersham Biosciences, Inc.) and 0.5 mM ascorbate for 16 h at 37 °C. Cells were washed, preincubated in culture medium for two 1-h incubations, and removed from dishes by pipetting with ice-cold KGlu buffer (20 mM HEPES, pH 7.2, 120 mM potassium glutamate (KGlu), 20 mM potassium acetate, 2 mM EGTA, and 0.1% bovine serum albumin). Cells were permeabilized by a single passage through a stainless steel ball homogenizer (28) and preincubated with KGlu buffer adjusted to 11 mM EGTA for 1 h on ice. Permeable cells were primed in incubations for 30 min at 30 °C in KGlu buffer containing 2 mM MgATP plus 1 mg/ml rat brain cytosol. Following two washes, the permeable cells were preincubated with antibodies where indicated for 1 h on ice and incubated at 30 °C for 3 min in triggering reactions containing KGlu buffer with free Ca2+ adjusted to 1 mM plus 0.1 mg/ml rat brain cytosol. Reactions were terminated by chilling followed by sedimentation at 2,000 × g for 10 min. [3H]NE in the supernatants and the 1% Triton X-100-solubilized cell pellets were used to calculate Ca2+-dependent [3H]NE release as a percentage of total [3H]NE in each incubation.

Miscellaneous Procedures-- SDS-polyacrylamide gel electrophoresis and immunoblotting analyses were performed as described previously (23). Immunostaining of Syts I and IX in PC12 cells was also performed as described previously (20, 22). Preparation of GST fusion proteins and the phosphatidylserine/phosphatidylcholine (PS/PC; 1:1, w/w) (or PC) liposome binding assay were also carried out as described elsewhere (19, 29). Syt I-deficient PC12 cells were isolated as a G418-resistant cell line following transfection with a pcDNA3.1 plasmid containing a rat Syt I cDNA sequence (-22 to 109) in reverse orientation. Immunoblotting indicated the complete absence of Syt I protein but normal levels of Syt IX, syntaxin 1A, VAMP2, and SNAP-25.

    RESULTS AND DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

Synaptotagmin has been found to represent a large protein family in both vertebrates and invertebrates, and 13 isoforms have been identified in the rat and mouse (4, 23, 24) (Fig. 1C). Since several other presynaptic proteins show functional redundancy in the brain (e.g. synapsins, complexins, and SV2s) (30-32), we hypothesized that other Syt isoforms may compensate for the function of Syt I in the Syt I-deficient PC12 cells. To test this hypothesis, we generated a specific antibody against each Syt isoform (Syts I-XIII)2 and examined its expression in normal and Syt I-deficient PC12 cell lines (PC12-a and -b). Quantitative analysis by using the recombinant Syts I-XIII with a T7 tag indicated that only the Syt IX isoform (formally called Syt V) (33, 34)2 is expressed as abundantly as the Syt I isoform in both PC12 cell lines but that it is less abundant in brain (Fig. 1, A and B). The most important finding was that the Syt I expression level is dramatically reduced in PC12-b cells (less than 5% of that of normal PC12-a cells) and that the Syt IX expression level is significantly higher than that of normal PC12 cells (Fig. 1B), suggesting that Syt IX may substitute for Syt I function in PC12-b cells. Consistent with this hypothesis, the phylogenetic distance between invertebrate Syt I and mouse Syt IX is indistinguishable from that between invertebrate Syt I and mouse Syt I (Fig. 1C, boxed), and the Ca2+-dependent phospholipid binding properties of Syts I, II, and IX are the same in terms of affinity for Ca2+ and specificity for phospholipids (19, 29). The C2A domain of Syt IX fused to GST bound PS/PC liposomes in a Ca2+-dependent manner but did not bind PC liposomes alone, irrespective of the presence of Ca2+ (Fig. 1D).


View larger version (37K):
[in this window]
[in a new window]
 
Fig. 1.   Expression of Syt IX, a closely related isoform of Syt I, in PC12 cells. A, expression of Syts I, II, and IX in normal and Syt I-deficient PC12 cell lines (PC12-a and PC12-b cells, respectively). The same amount of recombinant T7-tagged Syt I, II, or IX expressed in COS-7 cells (lanes 1-3), total homogenates of two PC12 cell lines (20 µg; lanes 4 and 5), and of adult mouse brain (20 µg; lane 6) were loaded on 10% SDS-polyacrylamide gel and immunoblotted with anti-T7 (bottom panel) or anti-Syt I, II, or IX specific antibody. The specificity of each antibody was confirmed by using recombinant T7-Syts I, II, and IX expressed in COS-7 cells (lanes 1-3). The positions of the molecular weight markers (× 10-3) are shown at the right. B, relative amounts of Syt I (open bars) and Syt IX (closed bars). Immunoreactive bands in A were captured by Gel Print 2000i/VGA and analyzed with Basic Quantifier Software (Bio Image). The intensities of Syt I and Syt IX in PC12 cells were calibrated by T7-tagged recombinant proteins (bottom panel in A). C, phylogenetic analysis of mouse Syts I-XIII and invertebrate Syt I by the CLUSTALW program (24). D, Ca2+-dependent phospholipid (PS/PC or PC liposome) binding activity of the C2A domain of Syt II and Syt IX fused to GST as previously described (19, 29). Open bars indicate phospholipid binding in the presence of 2 mM EGTA, and closed bars, in the presence of 1 mM Ca2+. C. elegans, Caenorhabditis elegans.

If Syt IX compensates for the function of Syt I in Syt I-deficient PC12 cells, the Syt IX would be expected to be localized to dense-core vesicles. Immunocytochemical studies indicated that Syt IX was present at the tips of neurites where dense-core vesicles are enriched, and it closely co-localized with Syt I (Fig. 2, Syt IX in green (A), Syt I in red (B), and overlay in yellow (C)). The specificity of the anti-Syt IX antibody was confirmed by incubation with antigenic peptide (Fig. 2, D and E). To examine the dynamics of Syt IX molecules during Ca2+-dependent exocytosis, Abs directed against the luminal domain of Syt IX conjugated to fluorescein and the luminal domain of Syt I conjugated to rhodamine were added to the culture medium (24, 35), and the cells were stimulated with a low or high concentration of KCl. Uptake of both the fluorescein-Syt IX Ab and rhodamine-Syt I Ab into neurites and cell body occurred only at depolarizing KCl concentrations (Fig. 3, A-D and G-J). Co-localization of the fluorescein-Syt IX Ab and the rhodamine-Syt I Ab (Fig. 3, C and I, arrowheads) indicated that Syt I and IX proteins are present on the same vesicles that undergo Ca2+-dependent exocytosis.


View larger version (7K):
[in this window]
[in a new window]
 
Fig. 2.   Co-localization of Syt I and Syt IX in nerve growth factor-differentiated PC12 cells. A, Syt IX in green (anti-Syt IX-N, 1 µg/ml). B, Syt I in red (SYA148, 1:250 dilution). C, overlay between Syts I and IX (in yellow). D and E, only the Syt IX signals (green in D) disappeared in the presence of antigenic Syt IX N-terminal peptide. E, Syt I in red. Immunoreactivity was analyzed with a fluorescence microscope attached to a laser confocal scanner unit CSU 10 (20) as described under "Experimental Procedures." Scale bar = 20 µM.


View larger version (31K):
[in this window]
[in a new window]
 
Fig. 3.   Essential role of Syt IX in Ca2+-dependent NE release in PC12 cells. A and G, high KCl (56 mM)-dependent uptake of fluorescein-labeled anti-Syt IX-N Ab. B and H, high KCl-dependent uptake of rhodamine-labeled anti-Syt I-N Ab. C and I, overlay between A and B and between G and H, respectively. Arrowheads indicate the colocalization of Syts I and IX. E, low KCl (5.6 mM)-dependent uptake of fluorescein-labeled anti-Syt IX-N and rhodamine-labeled anti-Syt I-N Abs. D, F, and J, light-field image of A, E, and G, respectively. Scale bar = 20 µM. K, left, effect of Syt IX-C2A (circles), Syt I-C2A (triangles), or preimmune (squares) IgGs on Ca2+-dependent NE release from permeable PC12 cells. Middle, inhibitory effects of Syt I (0.3 mg/ml) and Syt IX (2 mg/ml) IgGs on Ca2+-dependent NE release were nonadditive at maximally effective concentrations for each antibody. Right, Fab fragments derived from Syt I and Syt IX IgGs strongly inhibited Ca2+-dependent NE release from wild type permeable PC12 cells (open symbols). In contrast, Syt IX, but not Syt I, Fab fragments inhibited Ca2+-dependent NE release from Syt I-deficient PC12 cells (closed symbols). Shown for Syt I Fab is a buffer control, which contained high concentrations of HEPES (closed square). Preparation of the permeable PC12 cells, measurements of NE release, and antibody inhibition studies were performed as described previously (26-28). Because the PC12-b cells exhibited deficiencies in NE uptake, we used Syt I antisense PC12 cell lines that completely lack Syt I for the NE release assays. WT, wild type.

We had previously shown that inhibition of Ca2+/phospholipid binding to the C2A domain of Syt I by anti-Syt I-C2A Ab blocks neurotransmitter release in the squid giant synapse and superior cervical ganglion neurons (17, 18). Because the role of Syts in Ca2+-dependent exocytosis in PC12 cells is unclear (12), we introduced Syt C2A antibodies into permeabilized PC12 cells (26-28) to assess their effect on Ca2+-dependent NE release. The Ab against the C2A domain of Syt IX (anti-Syt IX-C2A) inhibited Ca2+-dependent NE release in a dose-dependent manner with maximal inhibition at about 50% (Fig. 3K, left, circles), whereas a preimmune Ab did not have any significant effect (Fig. 3K, left, squares). Similar results were obtained when the anti-Syt I-C2A Ab was introduced into permeable PC12 cells with maximal inhibition at about 50% (Fig. 3K, left, triangles). To analyze the functional relationship between Syts I and IX in NE release, the anti-Syt I-C2A and anti-Syt IX-C2A Abs were simultaneously introduced into PC12 cells. No significant additive effect of these two antibodies was observed at maximally effective concentrations of both antibodies (Fig. 3K, middle).

To assess whether antibody inhibition could result from steric effects or cross-linking of bivalent IgGs, we tested Fab fragments of the Abs. Fab fragments from either the Syt IX-C2A or the Syt I-C2A Ab strongly inhibited Ca2+-dependent NE release from wild type PC12 cells with maximal inhibition exceeding 80% (Fig. 3K, right, open symbols). As anticipated, the Syt I-C2A Fab fragments failed to inhibit Ca2+-dependent NE release from Syt I-deficient PC12 cells, whereas the Syt IX-C2A Fab fragments were fully inhibitory (Fig. 3K, right, closed symbols). The greater inhibitory effect of the Fab fragments compared with IgGs suggests that full access of larger IgGs to the C2A domain may be limited, which could be due to C2A domain-protein interactions that may be important for transmitter secretion (for a review, see Ref. 4). Alternatively, cross-linking of Syt I or IX isoforms by bivalent IgGs may allow residual Syt function in NE release. The results for Fab fragments indicate that inhibition of either Syt I or Syt IX in wild type PC12 cells is sufficient to block Ca2+-dependent exocytosis. This suggests that Syts I and IX function interdependently, which is consistent with our finding that both reside on the same vesicles and with our previous studies showing that Syts I and IX can form Ca2+-dependent hetero-oligomers (36).

In summary, several lines of evidence indicate that Syt IX is a major Syt isoform that is required for Ca2+-dependent secretion in PC12 cells. First, in wild type PC12 cells, Syt IX is expressed as abundantly as Syt I, and in Syt I-deficient PC12 cells, the expression of Syt IX is up-regulated (Fig. 1). No other Syt isoforms including Syt VII, a recently proposed plasma membrane Ca2+ sensor (37), are expressed abundantly (although Syt IV, a third isoform expressed in PC12 cells, is present at <5% of the level of Syt I). Second, both Syt I and Syt IX are present on the same vesicles that undergo Ca2+-dependent exocytosis (Figs. 2 and 3). Third, the Ca2+-dependent binding of the Syt IX C2A domain to phospholipids (Fig. 1) is similar to that of the Syt I C2A domain (19, 29), and similar Ca2+-dependent interactions of Syt I (38) and Syt IX with SNAP-25 have been characterized.2 Last, Fab fragments from either Syt I-C2A or Syt IX-C2A Abs almost completely inhibited Ca2+-dependent NE release in PC12 cells (Fig. 3). Based on these results, we propose that PC12 cells utilize two Ca2+ sensors, Syts I and IX, on the same vesicles that function cooperatively to mediate the Ca2+ triggering of exocytosis. This hypothesis can account for the finding that Syt I-deficient PC12 cells exhibit normal Ca2+-dependent NE release; Syt IX can function as an alternate Ca2+ sensor.

    ACKNOWLEDGEMENTS

We thank Eiko Kanno and Yukie Ogata for technical assistance.

    FOOTNOTES

* This work was supported in part by grants from the Science and Technology Agency to Japan (to K. M.), Grant 13780624 from the Ministry of Education, Science, and Culture of Japan (to M. F.), and National Institutes of Health Grant DK25861 (to T. F. J. M.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ To whom correspondence should be addressed. Tel.: 81-48-467-9745; Fax: 81-48-467-9744; E-mail: mnfukuda@brain.riken.go.jp.

Published, JBC Papers in Press, December 21, 2001, DOI 10.1074/jbc.C100588200

2 X. Zhang, M. J. Kim-Miller, M. Fukuda, J. A. Kowalchyck, and T. F. J. Martin, submitted for publication.

    ABBREVIATIONS

The abbreviations used are: Syt, synaptotagmin; Ab, antibody; GST, glutathione S-transferase; NE, norepinephrine; PC, phosphatidylcholine; PS, phosphatidylserine.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

1. Bennett, M. R. (1999) Prog. Neurobiol. 59, 243-277
2. Augustine, G. J. (2001) Curr. Opin. Neurobiol. 11, 320-326
3. Fernandez-Chacon, R., Konigstorfer, A., Gerber, S. H., Garcia, J., Matos, M. F., Stevens, C. F., Brose, N., Rizo, J., Rosenmund, C., and Südhof, T. C. (2001) Nature 410, 41-49
4. Marquèze, B., Berton, F., and Seagar, M. (2000) Biochimie (Paris) 82, 409-420
5. Schiavo, G., Osborne, S. L., and Sgouros, J. G. (1998) Biochem. Biophys. Res. Commun. 248, 1-8
6. Fukuda, M., and Mikoshiba, K. (1997) Bioessays 19, 593-603
7. Elferink, L. A., Peterson, M. R., and Scheller, R. H. (1993) Cell 72, 153-159
8. Lang, J., Fukuda, M., Zhang, H., Mikoshiba, K., and Wollheim, C. B. (1997) EMBO J. 16, 5837-5846
9. Ohara-Imaizumi, M., Fukuda, M., Niinobe, M., Misonou, H., Ikeda, K., Murakami, T., Kawasaki, M., Mikoshiba, K., and Kumakura, K. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 287-291
10. Desai, R. C., Vyas, B., Earles, C. A., Littleton, J. T., Kowalchyck, J. A., Martin, T. F. J., and Chapman, E. R. (2000) J. Cell Biol. 150, 1125-1136
11. Martin, T. F. J. (1994) Curr. Opin. Neurobiol. 4, 626-632
12. Shoji-Kasai, Y., Yoshida, A., Sato, K., Hoshino, T., Ogura, A., Kondo, S., Fujimoto, Y., Kuwahara, R., Kato, R., and Takahashi, M. (1992) Science 256, 1821-1823
13. Weiss, J. L., Archer, D. A., and Burgoyne, R. D. (2000) J. Biol. Chem. 275, 40082-40087
14. Chung, S. H., Takai, Y., and Holz, R. W. (1995) J. Biol. Chem. 270, 16714-16718
15. Orita, S., Sasaki, T., Komuro, R., Sakaguchi, G., Maeda, M., Igarashi, H., and Takai, Y. (1996) J. Biol. Chem. 271, 7257-7260
16. Chen, Y. A., Duvvuri, V., Schulman, H., and Scheller, R. H. (1999) J. Biol. Chem. 274, 26469-26476
17. Mikoshiba, K., Fukuda, M., Moreira, J. E., Lewis, F. M. T., Sugimori, M., Niinobe, M., and Llinás, R. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 10703-10707
18. Mochida, S., Fukuda, M., Niinobe, M., Kobayashi, H., and Mikoshiba, K. (1997) Neuroscience 77, 937-943
19. Fukuda, M., Kojima, T., and Mikoshiba, K. (1996) J. Biol. Chem. 271, 8430-8434
20. Fukuda, M., and Mikoshiba, K. (1999) J. Biol. Chem. 274, 31428-31434
21. Kida, Y., Sakaguchi, M., Fukuda, M., Mikoshiba, K., and Mihara, K. (2000) J. Cell Biol. 150, 719-730
22. Ibata, K., Fukuda, M., Hamada, T., Kabayama, H., and Mikoshiba, K. (2000) J. Neurochem. 74, 518-526
23. Fukuda, M., Kanno, E., and Mikoshiba, K. (1999) J. Biol. Chem. 274, 31421-31427
24. Fukuda, M., and Mikoshiba, K. (2001) Biochem. J. 354, 249-257
25. Sugimori, M., Tong, C.-K., Fukuda, M., Moreira, J. E., Kojima, T., Mikoshiba, K., and Llinás, R. (1998) Neuroscience 86, 39-51
26. Hay, J. C., and Martin, T. F. J. (1992) J. Cell Biol. 119, 139-151
27. Lomneth, R., Martin, T. F. J., and DasGupta, B. R. (1991) J. Neurochem. 57, 1413-1421
28. Martin, T. F. J. (1989) Methods Enzymol. 168, 225-233
29. Fukuda, M., Kojima, T., and Mikoshiba, K. (1997) Biochem. J. 323, 421-425
30. Reim, K., Mansour, M., Varoqueaux, F., McMahon, H. T., Südhof, T. C., Brose, N., and Rosenmund, C. (2001) Cell 104, 71-81
31. Janz, R., Goda, Y., Geppert, M., Missler, M., and Südhof, T. C. (1999) Neuron 24, 1003-1016
32. Rosahl, T. W., Spillane, D., Missler, M., Herz, J., Selig, D. K., Wolff, J. R., Hammer, R. E., Malenka, R. C., and Südhof, T. C. (1995) Nature 375, 488-493
33. Craxton, M., and Goedert, M. (1995) FEBS Lett. 361, 196-200
34. Hudson, A. W., and Birnbaum, M. J. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 5895-5899
35. Kraszewski, K., Mundigl, O., Daniell, L., Verderio, C., Matteoli, M., and De Camilli, P. (1995) J. Neurosci. 15, 4328-4342
36. Fukuda, M., and Mikoshiba, K. (2000) J. Biochem. (Tokyo) 128, 637-645
37. Sugita, S., Han, W., Butz, S., Liu, X., Fernandez-Chacon, R., Lao, Y., and Südhof, T. C. (2001) Neuron 30, 459-473
38. Gerona, R. R., Larsen, E. C., Kowalchyk, J. A., and Martin, T. F. J. (2000) J. Biol. Chem. 275, 6328-6336


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.


This article has been cited by other articles:


Home page
Am. J. Physiol. Cell Physiol.Home page
W. H. Roden, J. B. Papke, J. M. Moore, A. L. Cahill, H. Macarthur, and A. B. Harkins
Stable RNA interference of synaptotagmin I in PC12 cells results in differential regulation of transmitter release
Am J Physiol Cell Physiol, December 1, 2007; 293(6): C1742 - C1752.
[Abstract] [Full Text] [PDF]


Home page
GENES CELLSHome page
T. Tsuboi and M. Fukuda
Synaptotagmin VII modulates the kinetics of dense-core vesicle exocytosis in PC12 cells
Genes Cells, April 1, 2007; 12(4): 511 - 519.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
K. L. Lynch and T. F. J. Martin
Synaptotagmins I and IX function redundantly in regulated exocytosis but not endocytosis in PC12 cells
J. Cell Sci., February 15, 2007; 120(4): 617 - 627.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
J. M. Moore, J. B. Papke, A. L. Cahill, and A. B. Harkins
Stable gene silencing of synaptotagmin I in rat PC12 cells inhibits Ca2+-evoked release of catecholamine
Am J Physiol Cell Physiol, August 1, 2006; 291(2): C270 - C281.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
G. Nagy, J. H. Kim, Z. P. Pang, U. Matti, J. Rettig, T. C. Sudhof, and J. B. Sorensen
Different Effects on Fast Exocytosis Induced by Synaptotagmin 1 and 2 Isoforms and Abundance But Not by Phosphorylation
J. Neurosci., January 11, 2006; 26(2): 632 - 643.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
P. Wang, M. C. Chicka, A. Bhalla, D. A. Richards, and E. R. Chapman
Synaptotagmin VII Is Targeted to Secretory Organelles in PC12 Cells, Where It Functions as a High-Affinity Calcium Sensor
Mol. Cell. Biol., October 1, 2005; 25(19): 8693 - 8702.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
A. Bhalla, W. C. Tucker, and E. R. Chapman
Synaptotagmin Isoforms Couple Distinct Ranges of Ca2+, Ba2+, and Sr2+ Concentration to SNARE-mediated Membrane Fusion
Mol. Biol. Cell, October 1, 2005; 16(10): 4755 - 4764.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
Y. Haberman, I. Ziv, Y. Gorzalczany, M. Fukuda, and R. Sagi-Eisenberg
Classical protein kinase C(s) regulates targeting of synaptotagmin IX to the endocytic recycling compartment
J. Cell Sci., April 15, 2005; 118(8): 1641 - 1649.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
Y. Atiya-Nasagi, H. Cohen, O. Medalia, M. Fukudan, and R. Sagi-Eisenberg
O-glycosylation is essential for intracellular targeting of synaptotagmins I and II in non-neuronal specialized secretory cells
J. Cell Sci., April 1, 2005; 118(7): 1363 - 1372.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Fukuda, E. Kanno, M. Satoh, C. Saegusa, and A. Yamamoto
Synaptotagmin VII Is Targeted to Dense-core Vesicles and Regulates Their Ca2+-dependent Exocytosis in PC12 Cells
J. Biol. Chem., December 10, 2004; 279(50): 52677 - 52684.
[Abstract] [Full Text] [PDF]


Home page
J BiochemHome page
M. Fukuda and A. Yamamoto
Effect of Forskolin on Synaptotagmin IV Protein Trafficking in PC12 Cells
J. Biochem., August 1, 2004; 136(2): 245 - 253.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
M. Iezzi, G. Kouri, M. Fukuda, and C. B. Wollheim
Synaptotagmin V and IX isoforms control Ca2+-dependent insulin exocytosis
J. Cell Sci., July 1, 2004; 117(15): 3119 - 3127.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Morenilla-Palao, R. Planells-Cases, N. Garcia-Sanz, and A. Ferrer-Montiel
Regulated Exocytosis Contributes to Protein Kinase C Potentiation of Vanilloid Receptor Activity
J. Biol. Chem., June 11, 2004; 279(24): 25665 - 25672.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
A. Imai, S. Yoshie, T. Nashida, H. Shimomura, and M. Fukuda
The small GTPase Rab27B regulates amylase release from rat parotid acinar cells
J. Cell Sci., April 15, 2004; 117(10): 1945 - 1953.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Rickman, D. A. Archer, F. A. Meunier, M. Craxton, M. Fukuda, R. D. Burgoyne, and B. Davletov
Synaptotagmin Interaction with the Syntaxin/SNAP-25 Dimer Is Mediated by an Evolutionarily Conserved Motif and Is Sensitive to Inositol Hexakisphosphate
J. Biol. Chem., March 26, 2004; 279(13): 12574 - 12579.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Fukuda, E. Kanno, and A. Yamamoto
Rabphilin and Noc2 Are Recruited to Dense-core Vesicles through Specific Interaction with Rab27A in PC12 Cells
J. Biol. Chem., March 26, 2004; 279(13): 13065 - 13075.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
O.-H. Shin, A. Maximov, B. K. Lim, J. Rizo, and T. C. Sudhof
Unexpected Ca2+-binding properties of synaptotagmin 9
PNAS, February 24, 2004; 101(8): 2554 - 2559.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
T. Sadakata, A. Mizoguchi, Y. Sato, R. Katoh-Semba, M. Fukuda, K. Mikoshiba, and T. Furuichi
The Secretory Granule-Associated Protein CAPS2 Regulates Neurotrophin Release and Cell Survival
J. Neurosci., January 7, 2004; 24(1): 43 - 52.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Wang, C.-T. Wang, J. Bai, M. B. Jackson, and E. R. Chapman
Mutations in the Effector Binding Loops in the C2A and C2B Domains of Synaptotagmin I Disrupt Exocytosis in a Nonadditive Manner
J. Biol. Chem., November 21, 2003; 278(47): 47030 - 47037.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
Y. Haberman, E. Grimberg, M. Fukuda, and R. Sagi-Eisenberg
Synaptotagmin IX, a possible linker between the perinuclear endocytic recycling compartment and the microtubules
J. Cell Sci., November 1, 2003; 116(21): 4307 - 4318.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Biol.Home page
M. Dong, D. A. Richards, M. C. Goodnough, W. H. Tepp, E. A. Johnson, and E. R. Chapman
Synaptotagmins I and II mediate entry of botulinum neurotoxin B into cells
J. Cell Biol., September 29, 2003; 162(7): 1293 - 1303.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Physiol.Home page
J. B. Sorensen, R. Fernandez-Chacon, T. C. Sudhof, and E. Neher
Examining Synaptotagmin 1 Function in Dense Core Vesicle Exocytosis under Direct Control of Ca2+
J. Gen. Physiol., August 25, 2003; 122(3): 265 - 276.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Biol.Home page
W. C. Tucker, J. M. Edwardson, J. Bai, H.-J. Kim, T. F.J. Martin, and E. R. Chapman
Identification of synaptotagmin effectors via acute inhibition of secretion from cracked PC12 cells
J. Cell Biol., July 21, 2003; 162(2): 199 - 209.
[Abstract] [Full Text] [PDF]


Home page
J BiochemHome page
M. Fukuda
Molecular Cloning, Expression, and Characterization of a Novel Class of Synaptotagmin (Syt XIV) Conserved from Drosophila to Humans
J. Biochem., May 1, 2003; 133(5): 641 - 649.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Fukuda, E. Kanno, Y. Ogata, C. Saegusa, T. Kim, Y. P. Loh, and A. Yamamoto
Nerve Growth Factor-dependent Sorting of Synaptotagmin IV Protein to Mature Dense-core Vesicles That Undergo Calcium-dependent Exocytosis in PC12 Cells
J. Biol. Chem., January 24, 2003; 278(5): 3220 - 3226.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Fukuda and T. S. Kuroda
Slac2-c (Synaptotagmin-like Protein Homologue Lacking C2 Domains-c), a Novel Linker Protein that Interacts with Rab27, Myosin Va/VIIa, and Actin
J. Biol. Chem., November 1, 2002; 277(45): 43096 - 43103.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Fukuda, E. Kanno, C. Saegusa, Y. Ogata, and T. S. Kuroda
Slp4-a/Granuphilin-a Regulates Dense-core Vesicle Exocytosis in PC12 Cells
J. Biol. Chem., October 11, 2002; 277(42): 39673 - 39678.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Fukuda
Vesicle-associated Membrane Protein-2/Synaptobrevin Binding to Synaptotagmin I Promotes O-Glycosylation of Synaptotagmin I
J. Biol. Chem., August 9, 2002; 277(33): 30351 - 30358.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Saegusa, M. Fukuda, and K. Mikoshiba
Synaptotagmin V Is Targeted to Dense-core Vesicles That Undergo Calcium-dependent Exocytosis in PC12 Cells
J. Biol. Chem., June 28, 2002; 277(27): 24499 - 24505.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Fukuda, T. S. Kuroda, and K. Mikoshiba
Slac2-a/Melanophilin, the Missing Link between Rab27 and Myosin Va. IMPLICATIONS OF A TRIPARTITE PROTEIN COMPLEX FOR MELANOSOME TRANSPORT
J. Biol. Chem., March 29, 2002; 277(14): 12432 - 12436.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/7/4601    most recent
C100588200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar